
    
      This is a Phase II prospective, consecutive enrolling, non-randomized multi-center clinical
      evaluation of the safety and effectiveness of the Ovation Abdominal Stent Graft System when
      used in the treatment of patients with AAA (Treatment Group) as compared to a performance
      goal (Control Group).

      150 study patients will be enrolled at up to 40 institutions. An additional 100 study
      patients will be enrolled in the continued access phase.
    
  